| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.0054 | 1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |